Table of Content

1 Vaccine for Influenza Market Overview
1.1 Vaccine for Influenza Product Overview
1.2 Vaccine for Influenza Market Segment by Type
1.2.1 Trivalent Influenza Vaccine
1.2.2 Quadrivalent Influenza Vaccine
1.3 Global Vaccine for Influenza Market Size by Type
1.3.1 Global Vaccine for Influenza Market Size Overview by Type (2018-2029)
1.3.2 Global Vaccine for Influenza Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vaccine for Influenza Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine for Influenza Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vaccine for Influenza Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vaccine for Influenza Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vaccine for Influenza Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vaccine for Influenza Sales Breakdown by Type (2018-2024)
2 Global Vaccine for Influenza Market Competition by Company
2.1 Global Top Players by Vaccine for Influenza Sales (2018-2024)
2.2 Global Top Players by Vaccine for Influenza Revenue (2018-2024)
2.3 Global Top Players by Vaccine for Influenza Price (2018-2024)
2.4 Global Top Manufacturers Vaccine for Influenza Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine for Influenza Market Competitive Situation and Trends
2.5.1 Vaccine for Influenza Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine for Influenza Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccine for Influenza Market
2.8 Key Manufacturers Vaccine for Influenza Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine for Influenza Status and Outlook by Region
3.1 Global Vaccine for Influenza Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vaccine for Influenza Historic Market Size by Region
3.2.1 Global Vaccine for Influenza Sales in Volume by Region (2018-2024)
3.2.2 Global Vaccine for Influenza Sales in Value by Region (2018-2024)
3.2.3 Global Vaccine for Influenza Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vaccine for Influenza Forecasted Market Size by Region
3.3.1 Global Vaccine for Influenza Sales in Volume by Region (2024-2029)
3.3.2 Global Vaccine for Influenza Sales in Value by Region (2024-2029)
3.3.3 Global Vaccine for Influenza Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vaccine for Influenza by Application
4.1 Vaccine for Influenza Market Segment by Application
4.1.1 6 Months to 3 Years
4.1.2 > 3 Years
4.2 Global Vaccine for Influenza Market Size by Application
4.2.1 Global Vaccine for Influenza Market Size Overview by Application (2018-2029)
4.2.2 Global Vaccine for Influenza Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vaccine for Influenza Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine for Influenza Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vaccine for Influenza Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vaccine for Influenza Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vaccine for Influenza Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vaccine for Influenza Sales Breakdown by Application (2018-2024)
5 North America Vaccine for Influenza by Country
5.1 North America Vaccine for Influenza Historic Market Size by Country
5.1.1 North America Vaccine for Influenza Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vaccine for Influenza Sales in Volume by Country (2018-2024)
5.1.3 North America Vaccine for Influenza Sales in Value by Country (2018-2024)
5.2 North America Vaccine for Influenza Forecasted Market Size by Country
5.2.1 North America Vaccine for Influenza Sales in Volume by Country (2024-2029)
5.2.2 North America Vaccine for Influenza Sales in Value by Country (2024-2029)
6 Europe Vaccine for Influenza by Country
6.1 Europe Vaccine for Influenza Historic Market Size by Country
6.1.1 Europe Vaccine for Influenza Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vaccine for Influenza Sales in Volume by Country (2018-2024)
6.1.3 Europe Vaccine for Influenza Sales in Value by Country (2018-2024)
6.2 Europe Vaccine for Influenza Forecasted Market Size by Country
6.2.1 Europe Vaccine for Influenza Sales in Volume by Country (2024-2029)
6.2.2 Europe Vaccine for Influenza Sales in Value by Country (2024-2029)
7 Asia-Pacific Vaccine for Influenza by Region
7.1 Asia-Pacific Vaccine for Influenza Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine for Influenza Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vaccine for Influenza Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vaccine for Influenza Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vaccine for Influenza Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine for Influenza Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vaccine for Influenza Sales in Value by Region (2024-2029)
8 Latin America Vaccine for Influenza by Country
8.1 Latin America Vaccine for Influenza Historic Market Size by Country
8.1.1 Latin America Vaccine for Influenza Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vaccine for Influenza Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vaccine for Influenza Sales in Value by Country (2018-2024)
8.2 Latin America Vaccine for Influenza Forecasted Market Size by Country
8.2.1 Latin America Vaccine for Influenza Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vaccine for Influenza Sales in Value by Country (2024-2029)
9 Middle East and Africa Vaccine for Influenza by Country
9.1 Middle East and Africa Vaccine for Influenza Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine for Influenza Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vaccine for Influenza Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vaccine for Influenza Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vaccine for Influenza Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine for Influenza Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vaccine for Influenza Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Vaccine for Influenza Products Offered
10.1.5 Sanofi Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Vaccine for Influenza Products Offered
10.2.5 CSL Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Vaccine for Influenza Products Offered
10.3.5 GSK Recent Development
10.4 Viatris
10.4.1 Viatris Company Information
10.4.2 Viatris Introduction and Business Overview
10.4.3 Viatris Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Viatris Vaccine for Influenza Products Offered
10.4.5 Viatris Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Vaccine for Influenza Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information
10.6.2 Hualan Bio Introduction and Business Overview
10.6.3 Hualan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Hualan Bio Vaccine for Influenza Products Offered
10.6.5 Hualan Bio Recent Development
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Company Information
10.7.2 Changchun Institute of Biological Introduction and Business Overview
10.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changchun Institute of Biological Vaccine for Influenza Products Offered
10.7.5 Changchun Institute of Biological Recent Development
10.8 Sinovac
10.8.1 Sinovac Company Information
10.8.2 Sinovac Introduction and Business Overview
10.8.3 Sinovac Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sinovac Vaccine for Influenza Products Offered
10.8.5 Sinovac Recent Development
10.9 BCHT
10.9.1 BCHT Company Information
10.9.2 BCHT Introduction and Business Overview
10.9.3 BCHT Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.9.4 BCHT Vaccine for Influenza Products Offered
10.9.5 BCHT Recent Development
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Company Information
10.10.2 Jiangsu GDK Introduction and Business Overview
10.10.3 Jiangsu GDK Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jiangsu GDK Vaccine for Influenza Products Offered
10.10.5 Jiangsu GDK Recent Development
10.11 KM Biologics
10.11.1 KM Biologics Company Information
10.11.2 KM Biologics Introduction and Business Overview
10.11.3 KM Biologics Vaccine for Influenza Sales, Revenue and Gross Margin (2018-2024)
10.11.4 KM Biologics Vaccine for Influenza Products Offered
10.11.5 KM Biologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine for Influenza Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine for Influenza Industrial Chain Analysis
11.4 Vaccine for Influenza Market Dynamics
11.4.1 Vaccine for Influenza Industry Trends
11.4.2 Vaccine for Influenza Market Drivers
11.4.3 Vaccine for Influenza Market Challenges
11.4.4 Vaccine for Influenza Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine for Influenza Distributors
12.3 Vaccine for Influenza Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Trivalent Influenza Vaccine
Table 2. Major Company of Quadrivalent Influenza Vaccine
Table 3. Global Vaccine for Influenza Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 5. Global Vaccine for Influenza Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Vaccine for Influenza Sales by Type (2018-2024) & (US& Million)
Table 7. Global Vaccine for Influenza Market Share in Value by Type (2018-2024)
Table 8. Global Vaccine for Influenza Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Vaccine for Influenza Sales by Type (2024-2029) & (M Units)
Table 10. Global Vaccine for Influenza Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Vaccine for Influenza Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Vaccine for Influenza Sales Market Share in Value by Type (2024-2029)
Table 13. Global Vaccine for Influenza Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Vaccine for Influenza Sales by Type (2018-2024) & (M Units)
Table 15. North America Vaccine for Influenza Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Vaccine for Influenza Sales (M Units) by Type (2018-2024)
Table 17. Europe Vaccine for Influenza Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Vaccine for Influenza Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Vaccine for Influenza Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Vaccine for Influenza Sales (M Units) by Type (2018-2024)
Table 21. Latin America Vaccine for Influenza Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Vaccine for Influenza Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Vaccine for Influenza Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Vaccine for Influenza Sales by Company (2018-2024) & (M Units)
Table 25. Global Vaccine for Influenza Sales Share by Company (2018-2024)
Table 26. Global Vaccine for Influenza Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Vaccine for Influenza Revenue Share by Company (2018-2024)
Table 28. Global Market Vaccine for Influenza Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Vaccine for Influenza Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2022)
Table 32. Date of Key Manufacturers Enter into Vaccine for Influenza Market
Table 33. Key Manufacturers Vaccine for Influenza Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Vaccine for Influenza Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 37. Global Vaccine for Influenza Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Vaccine for Influenza Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Vaccine for Influenza Sales Market Share in Value by Region (2018-2024)
Table 40. Global Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 42. Global Vaccine for Influenza Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Vaccine for Influenza Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Vaccine for Influenza Sales Market Share in Value by Region (2024-2029)
Table 45. Global Vaccine for Influenza Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Vaccine for Influenza Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Vaccine for Influenza Sales by Application (2018-2024) & (M Units)
Table 48. Global Vaccine for Influenza Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Vaccine for Influenza Sales Market Share in Value by Application (2018-2024)
Table 51. Global Vaccine for Influenza Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Vaccine for Influenza Sales by Application (2024-2029) & (M Units)
Table 53. Global Vaccine for Influenza Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Vaccine for Influenza Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Vaccine for Influenza Sales Market Share in Value by Application (2024-2029)
Table 56. Global Vaccine for Influenza Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Vaccine for Influenza Sales by Application (2018-2024) (M Units)
Table 58. North America Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Vaccine for Influenza Sales by Application (2018-2024) (M Units)
Table 60. Europe Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Vaccine for Influenza Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Vaccine for Influenza Sales by Application (2018-2024) (M Units)
Table 64. Latin America Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Vaccine for Influenza Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Vaccine for Influenza Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 68. North America Vaccine for Influenza Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Vaccine for Influenza Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Vaccine for Influenza Sales Market Share in Value by Country (2018-2024)
Table 71. North America Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 72. North America Vaccine for Influenza Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Vaccine for Influenza Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Vaccine for Influenza Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 76. Europe Vaccine for Influenza Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Vaccine for Influenza Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Vaccine for Influenza Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 80. Europe Vaccine for Influenza Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Vaccine for Influenza Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Vaccine for Influenza Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Vaccine for Influenza Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Vaccine for Influenza Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Vaccine for Influenza Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Vaccine for Influenza Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Vaccine for Influenza Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Vaccine for Influenza Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Vaccine for Influenza Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Vaccine for Influenza Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Vaccine for Influenza Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Vaccine for Influenza Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Vaccine for Influenza Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Vaccine for Influenza Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Vaccine for Influenza Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Vaccine for Influenza Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Vaccine for Influenza Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Vaccine for Influenza Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Vaccine for Influenza Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Vaccine for Influenza Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Vaccine for Influenza Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Vaccine for Influenza Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Vaccine for Influenza Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Vaccine for Influenza Sales Market Share in Value by Country (2024-2029)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Vaccine for Influenza Product
Table 111. Sanofi Recent Development
Table 112. CSL Company Information
Table 113. CSL Introduction and Business Overview
Table 114. CSL Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Vaccine for Influenza Product
Table 116. CSL Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Vaccine for Influenza Product
Table 121. GSK Recent Development
Table 122. Viatris Company Information
Table 123. Viatris Introduction and Business Overview
Table 124. Viatris Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Viatris Vaccine for Influenza Product
Table 126. Viatris Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Introduction and Business Overview
Table 129. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Vaccine for Influenza Product
Table 131. AstraZeneca Recent Development
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Introduction and Business Overview
Table 134. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Hualan Bio Vaccine for Influenza Product
Table 136. Hualan Bio Recent Development
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Introduction and Business Overview
Table 139. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Changchun Institute of Biological Vaccine for Influenza Product
Table 141. Changchun Institute of Biological Recent Development
Table 142. Sinovac Company Information
Table 143. Sinovac Introduction and Business Overview
Table 144. Sinovac Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Sinovac Vaccine for Influenza Product
Table 146. Sinovac Recent Development
Table 147. BCHT Company Information
Table 148. BCHT Introduction and Business Overview
Table 149. BCHT Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. BCHT Vaccine for Influenza Product
Table 151. BCHT Recent Development
Table 152. Jiangsu GDK Company Information
Table 153. Jiangsu GDK Introduction and Business Overview
Table 154. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Jiangsu GDK Vaccine for Influenza Product
Table 156. Jiangsu GDK Recent Development
Table 157. KM Biologics Company Information
Table 158. KM Biologics Introduction and Business Overview
Table 159. KM Biologics Vaccine for Influenza Sales (M Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. KM Biologics Vaccine for Influenza Product
Table 161. KM Biologics Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Vaccine for Influenza Market Trends
Table 165. Vaccine for Influenza Market Drivers
Table 166. Vaccine for Influenza Market Challenges
Table 167. Vaccine for Influenza Market Restraints
Table 168. Vaccine for Influenza Distributors List
Table 169. Vaccine for Influenza Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine for Influenza Product Picture
Figure 2. Global Vaccine for Influenza Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaccine for Influenza Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Vaccine for Influenza Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Trivalent Influenza Vaccine
Figure 6. Global Trivalent Influenza Vaccine Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Quadrivalent Influenza Vaccine
Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Vaccine for Influenza Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Vaccine for Influenza Sales Market Share by Type in 2022 & 2029
Figure 11. North America Vaccine for Influenza Sales Market Share in Volume by Type in 2022
Figure 12. North America Vaccine for Influenza Sales Market Share in Value by Type in 2022
Figure 13. Europe Vaccine for Influenza Sales Market Share in Volume by Type in 2022
Figure 14. Europe Vaccine for Influenza Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Vaccine for Influenza Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Vaccine for Influenza Sales Market Share in Value by Type in 2022
Figure 17. Latin America Vaccine for Influenza Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Vaccine for Influenza Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Vaccine for Influenza Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Vaccine for Influenza Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine for Influenza Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine for Influenza Revenue in 2022
Figure 23. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of 6 Months to 3 Years
Figure 25. Global 6 Months to 3 Years Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of > 3 Years
Figure 27. Global > 3 Years Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Vaccine for Influenza Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Vaccine for Influenza Sales Market Share by Application in 2022 & 2029
Figure 30. North America Vaccine for Influenza Sales Market Share in Volume by Application in 2022
Figure 31. North America Vaccine for Influenza Sales Market Share in Value by Application in 2022
Figure 32. Europe Vaccine for Influenza Sales Market Share in Volume by Application in 2022
Figure 33. Europe Vaccine for Influenza Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Vaccine for Influenza Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Vaccine for Influenza Sales Market Share in Value by Application in 2022
Figure 36. Latin America Vaccine for Influenza Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Vaccine for Influenza Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Vaccine for Influenza Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Vaccine for Influenza Manufacturing Cost Structure
Figure 41. Vaccine for Influenza Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed